Global
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
132.60 |
Jan. 14, 2025 | USD 157.25 | 0.24% |
|
Australia |
|
2 |
83.50 |
Jan. 14, 2025 | USD 1.05 | 3.96% |
|
United States |
|
3 |
29.64 |
Jan. 14, 2025 | USD 4.25 | 1.59% |
|
France |
|
4 |
26.30 |
Jan. 14, 2025 | USD 99.01 | 4.67% |
|
United States |
|
5 |
20.98 |
Jan. 14, 2025 | USD 6.05 | 0.83% |
|
United States |
|
6 |
20.59 |
Jan. 14, 2025 | USD 267.04 | -0.35% |
|
United States |
|
7 |
18.81 |
Jan. 14, 2025 | USD 1.33 | 6.17% |
|
Australia |
|
8 |
17.40 |
Jan. 14, 2025 | USD 48.02 | 4.49% |
|
China |
|
9 |
16.66 |
Jan. 14, 2025 | USD 29.54 | -1.50% |
|
India |
|
10 |
16.02 |
Jan. 14, 2025 | USD 9.23 | 4.58% |
|
China |
|
11 |
14.72 |
Jan. 14, 2025 | USD 3.07 | 2.56% |
|
China |
|
12 |
14.17 |
Jan. 14, 2025 | USD 79.17 | -0.84% |
|
United States |
|
13 |
13.87 |
Jan. 14, 2025 | USD 14.70 | -4.54% |
|
United States |
|
14 |
13.34 |
Jan. 14, 2025 | USD 538.88 | -0.16% |
|
United States |
|
15 |
12.96 |
Jan. 14, 2025 | USD 7.15 | 0.36% |
|
India |
|
16 |
12.45 |
Jan. 14, 2025 | USD 15.60 | 0.97% |
|
United States |
|
17 |
12.05 |
Jan. 14, 2025 | USD 62.54 | -2.36% |
|
United States |
|
18 |
11.87 |
Jan. 14, 2025 | USD 32.39 | -1.98% |
|
India |
|
19 |
11.78 |
Jan. 14, 2025 | USD 21.45 | 2.32% |
|
New Zealand |
|
20 |
10.59 |
Jan. 14, 2025 | USD 1.50 | 7.10% |
|
China |
|
21 |
10.49 |
Jan. 14, 2025 | USD 79.30 | -0.05% |
|
United States |
|
22 |
10.41 |
Jan. 14, 2025 | USD 50.77 | 2.13% |
|
United States |
|
23 |
10.38 |
Jan. 14, 2025 | USD 0.63 | 10.03% |
|
China |
|
24 |
10.17 |
Jan. 14, 2025 | USD 185.40 | -0.68% |
|
Australia |
|
25 |
9.86 |
Jan. 14, 2025 | USD 0.20 | -2.77% |
|
Denmark |
|
26 |
9.83 |
Jan. 14, 2025 | USD 4.07 | 3.04% |
|
United States |
|
27 |
9.39 |
Jan. 14, 2025 | USD 57.52 | 1.79% |
|
United States |
|
28 |
9.36 |
Jan. 14, 2025 | USD 2.07 | -0.48% |
|
United States |
|
29 |
9.14 |
Jan. 14, 2025 | USD 35.79 | -1.16% |
|
United States |
|
30 |
8.70 |
Jan. 14, 2025 | USD 50.91 | 0.74% |
|
Poland |
|
31 |
8.36 |
Jan. 14, 2025 | USD 18.24 | -0.06% |
|
United States |
|
32 |
8.35 |
Jan. 14, 2025 | USD 252.89 | 2.41% |
|
United States |
|
33 |
8.34 |
Jan. 14, 2025 | USD 32.18 | 1.97% |
|
China |
|
34 |
8.24 |
Jan. 14, 2025 | USD 13.31 | 3.74% |
|
China |
|
35 |
7.69 |
Jan. 14, 2025 | USD 9.90 | 8.51% |
|
China |
|
36 |
7.61 |
Jan. 14, 2025 | USD 148.22 | 1.40% |
|
United States |
|
37 |
7.16 |
Jan. 14, 2025 | USD 329.06 | 0.76% |
|
Switzerland |
|
38 |
7.14 |
Jan. 14, 2025 | USD 4.00 | 1.74% |
|
China |
|
39 |
7.12 |
Jan. 14, 2025 | USD 362.80 | 0.50% |
|
United States |
|
40 |
7.02 |
Jan. 14, 2025 | USD 95.65 | 1.10% |
|
United States |
|
41 |
7.01 |
Jan. 14, 2025 | USD 228.83 | -0.62% |
|
United States |
|
42 |
6.99 |
Jan. 14, 2025 | USD 7.26 | -2.32% |
|
Canada |
|
43 |
6.98 |
Jan. 14, 2025 | USD 128.19 | -0.84% |
|
Japan |
|
44 |
6.86 |
Jan. 14, 2025 | USD 95.85 | 1.78% |
|
United States |
|
45 |
6.73 |
Jan. 14, 2025 | USD 54.93 | 4.23% |
|
United States |
|
46 |
6.60 |
Jan. 14, 2025 | USD 7.66 | -1.42% |
|
United States |
|
47 |
6.54 |
Jan. 14, 2025 | USD 119.40 | 0.87% |
|
Switzerland |
|
48 |
6.50 |
Jan. 14, 2025 | USD 0.10 | 0.09% |
|
United Kingdom |
|
49 |
6.49 |
Jan. 14, 2025 | USD 92.62 | -2.15% |
|
United States |
|
50 |
6.43 |
Jan. 14, 2025 | USD 12.08 | 3.01% |
|
China |
The Medical Instruments company with the highest Price to Book Ratio (P/B) is Pro Medicus Limited (ASX: PME.AX) at 132.60.
The Medical Instruments company with the lowest Price to Book Ratio (P/B) is Mettler-Toledo International Inc. (NYSE: MTD) at -174.28.
The top 10 Medical Instruments companies the Global by Price to Book Ratio (P/B) are Pro Medicus Limited, Nuwellis, Inc., Predilife S.A., iRhythm Technologies, Inc., Myomo, Inc., Insulet Corporation, PolyNovo Limited, APT Medical Inc., Poly Medicure Limited and Zhonghang Electronic Measuring Instruments Co.,Ltd.
The bottom 10 Medical Instruments companies by Price to Book Ratio (P/B) are Mettler-Toledo International Inc., BioSig Technologies, Inc., Sequana Medical NV, NeurAxis, Inc., Elutia Inc., Embecta Corp., Heart Test Laboratories, Inc., Biosynex SA, JMS Co.,Ltd. and Diagnósticos da América S.A..